trial · primary record
Selnoflast
Atherosclerosis
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 162 |
| Primary completion | 2028-02-28 |
| Primary endpoint | Change in mdsTBR (Most-diseased Segment TBR [Target-to-background Ratio]) of Index Vessel From Baseline to Week 12 in Participants With Baseline Elevated hsCRP (≥ 2 milligrams per liter [mg/L]) |
| Registry ID | NCT07448038 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:40.895Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07448038
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.